Riskpilot← Back to searchSign inGet full accessBiohit Oyj
OYJActiveY-tunnus 0703582-0Laippatie 1Manufacture of other chemical products n.e.c. · NACE 2059Est. 198836 employees
Revenue 2024
EUR 10,2B
+78020701% vs 2023
EBITDA margin
0.7%
+3197707% vs 2023
Equity ratio
83.9%
Financial strength
Net profit 2024
EUR 2,4B
+130037717% vs 2023
| Revenue | EUR 10,2B | +78020701% |
| EBITDA | EUR 70M | +3197707% |
| Net profit | EUR 2,4B | +130037717% |
| Total assets | EUR 13K | +24% |
| Equity | EUR 11K | +28% |
| Employees | 36 | — |
Legal name
Biohit Oyj
Y-tunnus number
0703582-0
Legal form
Julkinen osakeyhtiö
NACE code
2059 · Manufacture of other chemical products n.e.c.
Founded
9. maaliskuuta 1988
Share capital
EUR 2 350 351
Employees
36 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja yhdessä
Company purpose
Toimiala: Biolääketieteeseen ja biotekniikkaan liittyvä tutkimus- ja tuotekehittelytoiminta, sekä tuotanto, maahantuonti ja markkinointi.
Address
Laippatie 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 5 | 6 | 7 811 | 13 | 10 202 000 |
| Staff expenses | −2 | −3 | −2 765 | −3 | −3 048 000 |
| EBITDA | −2 | 0 | 1 520 | 2 | 70 000 |
| Depreciation & amort. | −2 | −2 | −142 | −0 | −67 000 |
| EBIT | −3 | −2 | 1 378 | 2 | 3 000 |
| Net financials | −0 | 0 | −238 | −3 | 183 000 |
| Profit before tax | −3 | −1 | 1 140 | −1 | 2 671 000 |
| Tax | 0 | 0 | 204 | −0 | 265 000 |
| Net profit | −3 | −2 | 936 | 2 | 2 407 000 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 9 | 8 | 9 031 | 11 | 13 |
| Equity | 8 | 7 | 7 062 | 9 | 11 |
| Long-term debt | 0 | — | 182 | 0 | 0 |
| Short-term debt | 1 | 2 | 1 787 | 2 | 2 |
| Total debt | 1 | 2 | 1 969 | 2 | 2 |
EBITDA margin
0.7%
This company
15.8%
Market median
-96% vs market
20202024
Equity ratio
83.9%
This company
38.2%
Market median
+120% vs market
20202024
Return on equity
21778863.6%
This company
18.4%
Market median
+118363289% vs market
20202024
Net profit margin
23.6%
This company
8.1%
Market median
+191% vs market
20202024
Asset turnover
774462.92×
This company
1.12×
Market median
+69148375% vs market
20202024
Debt / equity
0.19×
This company
0.62×
Market median
+69% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
JH Chief Executive Officer | Chief Executive Officer | 2022 |
JM Person with significant control | Person with significant control | 2023 |
| Former (6) | ||
TA | Audit | 2022 – 2023 |
SJ Chief Executive Officer | Chief Executive Officer | 2012 – 2021 |
PA | Audit | 2014 – 2022 |
OS Confidential Clerk | Confidential Clerk | 1992 – 2019 |
PH Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
JP Confidential Clerk | Confidential Clerk | 2021 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (5) | ||
| Chairperson | 2023 | |
| Board of Directors | 2021 | |
LF | Board of Directors | 2018 |
| Board of Directors | 2022 | |
| Board of Directors | 2023 | |
| Former (4) | ||
| Board of Directors | 2018 – 2022 | |
| Board of Directors | 2018 – 2023 | |
| Board of Directors | 2018 – 2021 | |
| Board of Directors | 2020 – 2021 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Biohit Oyj (this company)
Biohit Healthcare S.r.l., ItaliaBiohit Healthcare Ltd, Iso-BritanniaBoard members of Biohit Oyj also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tiina Annika Puukkoniemi | Audit | 0 companies |
| Jussi Henrik Hahtela | Chief Executive Officer | 0 companies |
| Semi Juhana Korpela | Chief Executive Officer | 0 companies |
| Pasi Antero Karppinen | Audit | 0 companies |
| Oili Sinikka Suovaniemi | Confidential Clerk | 0 companies |
| Jussi Mikael Sorvo | Person with significant control | 0 companies |
| Päivi Helena Siltala | Chief Executive Officer | 0 companies |
| Jukka Petteri Kainulainen | Confidential Clerk | 0 companies |
| Vesa-Pekka Juhani Silaskivi | Chairperson | 0 companies |
| Matti Heikki Aleksi Härkönen | Board of Directors | 0 companies |
| Franco Aiolfi | Board of Directors | 0 companies |
| Eero Heikki Lehti | Board of Directors | 0 companies |
| Timo Kalevi Joensuu | Board of Directors | 0 companies |
| Osmo Antero Suovaniemi | Board of Directors | 0 companies |
| Liu Feng | Board of Directors | 0 companies |
| Kalle Peter Mika Härkönen | Board of Directors | 0 companies |
| Lea Inkeri Paloheimo | Board of Directors | 0 companies |